The overall aim of this project is to use transgenic and gene- inactivated mouse models to determine metabolic pathways leading to the formation of the multiple forms of LDL and IDL found in human plasma. A particular focus is the delineation of the steps involved in the production of small, dense LDL particles. In humans, a predominance of small, dense LDL is associated with changes in triglyceride-rich lipoprotein metabolism, and with increased risk of atherosclerosis. Preliminary evidence from stable isotope kinetic studies in subjects with the small, dense LDL phenotype indicates an increase in rate of production and a reduction in rate of catabolism of large VLDL subspecies (Sf 60-400). These VLDL enter a metabolic cascade that gives rise to smaller VLDL remnant particles and intermediate density lipoproteins (IDL). We hypothesize that a subset of particles in this cascade can be further processed and remodeled to give rise to small, dense LDL. We further hypothesize a critical role for hepatic lipase in this process based on studies in humans, and preliminary evidence from hepatic lipase transgenic rabbits and hepatic lipase knockout mice. These studies will utilize a human apoB transgenic mouse strain that we have shown, in collaboration with Project 0008, to express high levels of multiple human-like LDL subclasses of high fat diets. Lipoproteins isolated from plasma an desolated perfused livers from these mice, as well s from mice with targeted inactivation of the LDL receptor, will be characterized and tested in vivo as potential metabolic precursors of individual ILD and LDL subspecies. Further genetic manipulations will allow testing the role of hepatic lipase and other regulatory proteins, including apoCIII and cholesteryl ester transfer protein, in modulating the distribution of LDL subclasses in vivo, and in particular, in mediating the formation of increased levels of IDL and small, dense LDL that may be of particular importance with regard to atherosclerosis risk. Once the key metabolic determinants of these species have been identified, future studies can be directed at testing their role in generating the atherogenic small, dense LDL phenotype in humans, and at evaluating the influence of other genetic and and environmental influences on its pathologic manifestations. This information, in turn, can be used to develop improved means of diagnosis and management of individuals who are at risk for atherosclerosis as a result of predisposition to this common trait.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL018574-26
Application #
6499620
Study Section
Project Start
2001-09-01
Project End
2003-09-29
Budget Start
Budget End
Support Year
26
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Lawrence Berkeley National Laboratory
Department
Type
DUNS #
078576738
City
Berkeley
State
CA
Country
United States
Zip Code
94720
Williams, Paul T; Blanche, Patricia J; Rawlings, Robin et al. (2005) Concordant lipoprotein and weight responses to dietary fat change in identical twins with divergent exercise levels 1. Am J Clin Nutr 82:181-7
Krauss, Ronald M (2005) Dietary and genetic probes of atherogenic dyslipidemia. Arterioscler Thromb Vasc Biol 25:2265-72
Ma, Ke; Forte, Trudy; Otvos, James D et al. (2005) Differential additive effects of endothelial lipase and scavenger receptor-class B type I on high-density lipoprotein metabolism in knockout mouse models. Arterioscler Thromb Vasc Biol 25:149-54
Kwiterovich Jr, Peter O; Cockrill, Steven L; Virgil, Donna G et al. (2005) A large high-density lipoprotein enriched in apolipoprotein C-I: a novel biochemical marker in infants of lower birth weight and younger gestational age. JAMA 293:1891-9
Dubrac, Sandrine; Lear, Steven R; Ananthanarayanan, Meena et al. (2005) Role of CYP27A in cholesterol and bile acid metabolism. J Lipid Res 46:76-85
Badzioch, Michael D; Igo Jr, Robert P; Gagnon, France et al. (2004) Low-density lipoprotein particle size loci in familial combined hyperlipidemia: evidence for multiple loci from a genome scan. Arterioscler Thromb Vasc Biol 24:1942-50
Berneis, Kaspar; Shames, David M; Blanche, Patricia J et al. (2004) Plasma clearance of human low-density lipoprotein in human apolipoprotein B transgenic mice is related to particle diameter. Metabolism 53:483-7
Rizzo, Manfredi; Taylor, John M; Barbagallo, Carlo M et al. (2004) Effects on lipoprotein subclasses of combined expression of human hepatic lipase and human apoB in transgenic rabbits. Arterioscler Thromb Vasc Biol 24:141-6
Georgieva, A M; van Greevenbroek, M M J; Krauss, R M et al. (2004) Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype. Arterioscler Thromb Vasc Biol 24:744-9
Mar, Rebecca; Pajukanta, Paivi; Allayee, Hooman et al. (2004) Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia. Circ Res 94:993-9

Showing the most recent 10 out of 233 publications